Search Results - "van Rijswijk, R.E.N."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group by Van Rijswijk, R.E.N., Jeziorski, K., Wagener, D.J.TH, Van Laethem, J.-L., Reuse, S., Baron, B., Wils, J.

    Published in European journal of cancer (1990) (01-09-2004)
    “…The aim of the study was to assess the response rate and toxicity of high-dose 24 h infusion of 5-fluorouracil (5FU) in metastatic adenocarcinoma of the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease by van Rijswijk, R. E. N., Hoekman, K., Burger, C. W., Verheijen, R. H. M., Vermorken, J. B.

    Published in Annals of oncology (01-12-1997)
    “…Background High-dose platinum-based regimens can produce responses in patients not responding to standard chemotherapy. As in many ovarian cancer patients the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin by Lopez Lopez, R, van Rijswijk, R E, Wagstaff, J, Pinedo, H M, Peters, G J

    Published in European journal of cancer (1990) (1994)
    “…Suramin has shown antitumour activity in vitro and in vivo. At plasma levels higher than 200 microM there is, however, excessive toxicity. We have, therefore,…”
    Get more information
    Journal Article
  6. 6

    The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-alpha treatment by Richters, C D, Burger, C W, van de Loosdrecht, A A, van Rijswijk, R E, Calame, W, Bleker, O P, Vermorken, J B, Kenemans, P, Beelen, R H

    Published in Cancer letters (15-01-1993)
    “…In patients with epithelial ovarian cancer (EOC), the cellular composition in the peritoneal cavity and the functional capacities of the peritoneal cells (PC)…”
    Get more information
    Journal Article
  7. 7